| UROLOGY MAIN SITE | GEN. ADULT UROLOGY | UROLOGIC ONCOLOGY | MALE UROLOGY | TRANSPLANT PROGRAM | |
| PELVIC MEDICINE, INCONTINENCE & RECONST. SURGERY | PEDIATRIC UROLOGY | MIN. INVASIVE SURGERY | |||
|
Arie Belldegrun, MD
a Curriculum Vitae
|
|
||||||||||||||||||||
| Educational Background | |
|
|
|
| Medical School: | 1967 - 1974 The Hebrew University Hadassah Medical School, Jerusalem, Israel |
| Residency: | 1984 - 1985 Chief Resident, Harvard Program in Urology: Brigham and Women's Hospital, Boston, Massachusetts; West Roxbury Veterans Administration Medical Center; The Children's Hospital Medical Center, Boston, MA 1983 - 1984 Senior Resident, Harvard Program in Urology 1982 - 1983 Junior Resident, Harvard Program in Urology, Boston, Massachusetts 1980 - 1982 Resident in General Surgery, Beilinson Medical Center, Tel Aviv University, Sackler School of Medicine 1979 - 1980 Resident, Department of Urology and Renal Transplantation Unit, Beilinson Medical Center, Tel Aviv University, Sackler School of Medicine 1976 - 1979 Research Fellow and Visiting Scientist Weizmann Institute of Science, Rehovot, Israel |
| Board Certifications & Fellowships: |
1985 - 1988 Fellow, Surgical Oncology, Surgery Branch, National Cancer Institute, NIH, Bethesda, Maryland |
| Professional Memberships | |
|
|
|
| American Association for Cancer Research American Association for Genitourinary Surgeons The American Association of Immunologists Fellow, American College of Surgeons American Israeli Mecical Society American Medical Association American Society of Clinical Oncologists American Urological Association, Inc. The Clinical Immunology Society European Society for Urological Oncology and Endocrinology The International Transplantation Society The Los Angeles Urologic Society Society of Basic Urologic Research Society for Biological Therapy Society of University Surgeons Society of Urologic Cryosurgeons The Society of Urologic Oncology Western Section, American Urological Association |
| Academic & Medical Staff Appointments | |
|
|
|
| 2000 - Roy and Carol Doumani Chair in Urologic Oncology, UCLA 1996 - Chief, Division of Urologic Oncology, Department of Urology, UCLA School of Medicine, Los Angeles, CA 1996 - Director of Urologic Research, Department of Urology, UCLA School of Medicine, Los Angeles, CA 1995 - Head, Genitourinary Oncology Program, Jonsson Comprehensive Cancer Center, Los Angeles, CA 1994 - Professor of Surgery/Urology, Head, Cancer Immunotherapy Program, Division of Urology, UCLA School of Medicine 1993 - Clinical Director, UCLA Prostate Disease Research Program 1993 - Surgical Director, UCLA Kidney Cancer Program 1990 - Associate Professor of Surgery/Urology, Head, Cancer Immunotherapy Program, Division of Urology, UCLA School of Medicine 1988 - Chief, Division of Urology, Olive-View Medical Center, Los Angeles, CA 1988 - Clinical Director, Adoptive Immunotherapy Core Laboratory, Jonsson Comprehensive Cancer Center, UCLA Center for the Health Sciences 1988-1994 - Associate Director, Genitourinary Oncology Program Area, Jonsson Comprehensive Cancer Center, UCLA Center for the Health Sciences 1988 - 1990 Assistant Professor of Surgery/Urology, Division of Urology, UCLA School of Medicine |
| Research & Clinical Interests | |
|
|
|
| Cancer Vaccine, gene therapy, immunotherapy, Cytokine research, adoptive immunotherapy, tumor vaccines, molecular engineering of tumor cells and tumor infiltrating lymphocytes Urologic oncology, clinical trials of biological therapy for advanced cancer, gene therapy |
| Awards & Honors | |
|
|
|
| Surgical Forum Award, Boston Surgical Society, 1984 The Chaim/Weizmann Postdoctoral Fellowship Award, American Committee for the Weizmann Institute of Science, New York, NY, 1981/82 The Maimonides Award, The State of Israel Bonds, Los Angeles, CA, 1992 CaP Cure Award, Association for the Cure of Cancer of the Prostate, Washington, D.C., 1993 Trustee, The Prostate Cancer Charitable Trust, Imperial Cancer Research Fund, London, England, 1995 Who's Who in America, 1995 Strathmore's Who's Who, 1997-98 Elected Member, American Association of Genitourinary Surgeons |
Additional Information |
|
|
|
|
Books:
Oliver RTD, Belldegrun A, Wrigley PFM Cancer Surveys. Cold Spring Harbour Laboratory Press, Plainview, New York, 1995.
Belldegrun A, Kirby RS, Newling DWW (ed.) New Perspectives in Prostate Cancer: Second Edition. Isis Medical Media Ltd., Oxford, UK, 2000.
Belldegrun A, Ritchie A, Figlin R, Oliver R, Vaughan E (Ed): Renal and Adrenal Tumors. Biology and Management. Oxford University Press. UK, 2003.
Patents/Biotechnology Affiliations
“Aggressive Prostate Cancer Clones Selected by Androgen Deprivation (LNCAP-A1 and LNCAP-A1/AD) and Uses Thereof”
M&A Ref. No: 30435.67USP1
Inventors: Cho-Lea Tso
“Novel Technique for Generating Dendritic Cells from DC14+ Precursors”
UCLA Preliminary Case No: LA98-097-01
Inventors: Andreas Hinkel, MD, PhD
“New Method of Gene Transfer into Dendritic Cells”
UCLA Preliminary Case No:
Inventors: Peter Mulders, MD, PhD
“PSA Positive Regulating (PSAR) Sequences and Uses Thereof”
UC Ref. No. 95-545-03
M&A Ref. No. 30435.35USU1
Inventors: Shen Pang, Ph.D.
Arie Belldegrun, M.D.
“Novel Nucleic Acid Molecules Comprising the Prostate Specific Antigen (PSA) Promoter and Uses Thereof”
Initially Filed November 9, 1994
Improvements filed September 1, 1995 (Based on U.S. CIP Application S/N 08/522,841)
Assigned International Publication Number WO 96/14875, May 23, 1996
Inventors: Shen Pang, Ph.D,
Arie Belldegrun, M.D.,
“Aggressive Prostate Cancer Sublines Selected by Androgen Deprivation”
Initially Filed January 28, 1999
UC Ref. No: LA99-158-02
M&A Ref. No: 30435.67USU1
Inventors: Cho-Lea Tso,
Arie Belldegrun, MD,
“Chimeric Transcriptional Regulatory Element Compositions and Methods for Increasing Prostate-Targeted Gene Expression”
International Patent No: PCT/US00/28444
Recorded: 8/6/2002
Filing date: 4/15/2002
Serial Number: 10110681
UCLA Ref. No: 2000-124-3
Inventors: Lily Wu, MD, PhD,
Michael Carey, PhD,
Arie Belldegrun, MD,
“Human Monoclonal Antibodies to Epidermal Growth Factor Receptor and Therapies”
Initially Filed December 1, 2000
Serial No. 09/728,429
Ref No: ABX-EGF-Dose
Inventors: Gisela Schwab, MD, Abgenix, Inc.
Michelle Lohner, Abgenix, Inc.
Lorin Roskos, Abgenix, Inc.
Michael Gallo, Abgenix, Inc.
Robert A. Figlin, MD,
Arie Belldegrun, MD,
Louis M. Weiner
“Kidney-Specific Tumor Vaccine Directed Against Kidney Tumor Antigen G-250”
US Patent No. 09/873,708
Filed February 13, 2000
UCLA Ref No: LA99-270-1
Inventors:
Cho-Lea
Publications: (Most recent)
Lam JS, Shvarts O, Belldegrun A. Kidney Cancer Management 2004: An Update for the Practicing General Urologist. Curr Urol Rep 5:1-3, 2004.
Shvarts O, Lam JS, Figlin RA, Belldegrun A. Heat Shock-Peptide Complex Vaccine as Adjuvant Therapy for High Risk Patients with Resected Renal Cell Carcinoma. Curr Urol Rep 5:11:12, 2004.
Kim HL, Lam JS, Belldegrun A: The Role of Lymphadenectomy in Renal Cell Carcinoma. Curr Urol Rep 5(1): 25-29, 2004. Review.
Kim HL, Zisman A, Han K, Figlin RA, Belldegrun A. Prognostic Significance of Venous Thrombus in Renal Cell Carcinoa: Is Renal Vein and Inferior Vena Cava Involvement Different? J Urol 171:588-591, 2004.
Palapattu GS, Kim HL, Belldegrun A. Advances in the Treatment of Genitourinary Cancer: Highlights from the 3rd Annual Society of Urologic Oncology Meeting. Rev Urol 5:232:234, 2004.
Foon K, Yang X, Weiner L, Belldegrun A, Figlin R, Crawford J, Rowinsky E, Dutcher J, Vogelzang N, Gollub J, Thompson J, Schwartz G, Bukowski R, Roskos L, Schwab G: Preclinical and Clinical Evaluation of ABX-EGF: A Fully Human Anti-Epidermal Growth Factor Receptor Antibody. Int'l J Radiation Oncology Biol. Phys.Vol. 58, No. 3: 984-990, 2004.
